title: Roundtable. Blueprint for conversion of patients on metformin and sulfonylurea to Glucovance.
authors.forename: A
authors.initials: A
authors.lastname: Roselli
authors.forename: J D
authors.initials: JD
authors.lastname: Hayes
authors.forename: R
authors.initials: R
authors.lastname: Seidner
authors.forename: V
authors.initials: V
authors.lastname: Marchione
authors.forename: C M
authors.initials: CM
authors.lastname: Snyder
authors.forename: K
authors.initials: K
authors.lastname: Mayes
authors.forename: C M
authors.initials: CM
authors.lastname: Stiernberg
authors.forename: L
authors.initials: L
authors.lastname: Milgram
mesh_terms: D003376:Counseling; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005905:Glyburide / Q000008:administration & dosage*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008687:Metformin / Q000008:administration & dosage*; D010349:Patient Compliance; D010353:Patient Education as Topic / Q000379:methods*; D013453:Sulfonylurea Compounds / Q000008:administration & dosage*; D014481:United States
chemical_list: D004338:Drug Combinations; C417231:Glucovance; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D008687:Metformin; D005905:Glyburide